#news #biotech A new target in multiple myeloma? TAK1 blocker boosts chemo’s cancer-killing power in preclinical study

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: A new target in multiple myeloma? TAK1 blocker boosts chemo’s cancer-killing power in preclinical study .A new target in multiple myeloma? TAK1 blocker boosts chemo’s cancer-killing power in preclinical study
arlene.weintraub
Mon, 10/18/2021 – 09:31

from FierceBiotech: Biotech https://ift.tt/2Z2URzG